文献速递牙周病

牙周治疗对2型糖尿病患者HbA1c变化的长期影响

Long-Term Effect of Periodontal Therapy on HbA1c Changes in Type 2 Diabetes.
PubMed 文献 · J Dent Res · 2025-08-16

这项纵向队列研究评估了非手术牙周治疗(NSPT)对154名伴牙周炎的2型糖尿病患者HbA1c及牙周指标的影响,并考虑了降糖药物变化。结果显示NSPT后12个月内HbA1c持续降低,基线HbA1c>8.0%者获益更显著。

要点

  • NSPT后3、6、9、12个月HbA1c分别降低0.70%、0.73%、0.68%、0.77%。
  • 基线HbA1c>8.0%组12个月HbA1c降低1.31%,≤8.0%组降低0.24%。
  • NSPT后12个月牙周炎症表面积(PISA)减少352.7 mm²。

核心结论

  • 非手术牙周治疗包括维护治疗可显著改善2型糖尿病患者的血糖结局,尤其对基线HbA1c>8.0%者效果更明显。

研究设计与样本

  • 纵向队列研究,纳入154名不吸烟的伴牙周炎2型糖尿病患者,基线接受初始牙周治疗并在3、6、9、12个月提供支持性牙周护理。

主要发现

  • 与基线相比,HbA1c在3、6、9、12个月分别降低0.70%、0.73%、0.68%、0.77%。
  • 12个月后PISA减少352.7 mm²,其他牙周健康参数(临床附着丧失、探诊深度、全口出血评分)在3个月显著降低并维持至12个月。
  • 基线HbA1c>8.0%组12个月HbA1c降低1.31%,而≤8.0%组降低0.24%。

关键数值与推荐

  • 基线平均HbA1c为8.4%±1.6%。
  • 按基线HbA1c分层:≤8.0%为可接受组(n=77),>8.0%为不可接受组(n=77)。

临床怎么用

  • 对伴牙周炎的2型糖尿病患者,尤其是基线HbA1c>8.0%者,应积极提供非手术牙周治疗及维护以改善血糖控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although prior studies have assessed the effect of nonsurgical periodontal therapy (NSPT) on glycemic management, most are short term and do not account for changes in diabetes medication. This longitudinal cohort study assessed the effect of NSPT on HbA1c levels and clinical periodontal measures of type 2 diabetes (T2D) patients with periodontitis. Medication changes up to 1 y prior to and 1 y after commencing NSPT were considered. A total of 154 nonsmoking T2D patients with periodontitis received initial periodontal treatment (professional mechanical plaque removal, subgingival instrumentation, root surface debridement) and oral hygiene instructions at baseline. Supportive periodontal care with repeated subgingival instrumentation for residual pockets was provided at 3, 6, 9, and 12 mo. A full-mouth periodontal examination assessing plaque, bleeding on probing, gingival suppuration, clinical attachment loss, and periodontal inflamed surface area (PISA) was conducted at baseline and at the follow-up visits. Glycemic management was monitored via point-of-care HbA1c testing at each follow-up, with HbA1c records up to 12 mo before NSPT obtained from patients. Linear mixed-effects models were applied to assess the effect of NSPT on HbA1c over time, controlling for important confounding effects such as medical history and changes in diabetes medications. The mean HbA1c at baseline was 8.4% ± 1.6%. Compared with baseline, HbA1c was lower by 0.70%, 0.73%, 0.68%, and 0.77% at 3, 6, 9, and 12 mo, respectively. PISA was reduced by 352.7 mm2 after 12 mo. Moreover, other periodontal health parameters (clinical attachment loss, probing pocket depth, and full-mouth bleeding score) were significantly reduced at 3 mo and sustained at 6, 9, and 12 mo. Participants were stratified by baseline HbA1c into "acceptable" (≤8.0%, n = 77) and "unacceptable" (>8.0%, n = 77) groups. The "unacceptable" group showed an HbA1c reduction of 1.31% at 12-mo follow-up compared with 0.24% in the "acceptable" group. The present study demonstrated that NSPT including maintenance significantly improved glycemic outcomes in T2D patients, particularly those with baseline HbA1c >8.0%.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Chee HK, Tan SHX, Tjakkes GHE, et al. Long-Term Effect of Periodontal Therapy on HbA1c Changes in Type 2 Diabetes. J Dent Res. 2025. PMID: 40817763. doi:10.1177/00220345251357875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。